Multicentre investigation of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Bulgarian hospitals - Interregional spread of ST11 NDM-1-producing K. pneumoniae.


Journal

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
ISSN: 1567-7257
Titre abrégé: Infect Genet Evol
Pays: Netherlands
ID NLM: 101084138

Informations de publication

Date de publication:
04 2019
Historique:
received: 03 10 2018
revised: 09 12 2018
accepted: 11 01 2019
pubmed: 18 1 2019
medline: 16 1 2020
entrez: 18 1 2019
Statut: ppublish

Résumé

The aim of this study was to investigate the mechanisms of beta-lactam-resistance and the clonal relatedness of carbapenem-nonsusceptible Klebsiella pneumoniae and Escherichia coli isolates, collected consecutively in eight centers in five Bulgarian cities from November 2014 to March 2018. Carbapenemase-producing enterobacteria were detected in all but one centers. Overall, 104 K. pneumoniae and one E. coli were analysed. Antimicrobial susceptibility and beta-lactamases were analysed. Conjugation experiments, plasmid fingerprinting and replicon typing, as well as MLST and ERIC-PCR were carried out. KPC-2 (51%) and NDM-1 (47%) were the main carbapenemases identified. KPC-2 producing K. pneumoniae were classified into 10 MLST-types. The four dominating MLST-types ST29, ST15, ST336 and ST902 comprised 79% of the KPC-2 producers. All but one of the NDM-1 producing isolates belonged to the MLST-type ST11 and were found in seven centers. Furthermore, single K. pneumoniae isolates producing VIM-1 (ST147) and OXA-48 (ST15) were identified. In addition to the carbapenemases, the ESBLs CTX-M-15, CTX-M-3, and SHV-12 as well as AmpC enzyme CMY-4 were found. The FIIAs-replicon-type was found in all KPC-2 producers while the A/C-replicons dominated in NDM-1 producing isolates. The single NDM-1 producing E. coli was determined as MLST-Type ST10 (Warwick scheme). The interregional clonal expansion of NDM-1 producing ST11 K. pneumoniae and the dissemination of bla

Identifiants

pubmed: 30654179
pii: S1567-1348(18)30767-6
doi: 10.1016/j.meegid.2019.01.013
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
beta-Lactamases EC 3.5.2.6
beta-lactamase NDM-1 EC 3.5.2.6

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

61-67

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Rumyana Markovska (R)

Medical University of Sofia, Medical Faculty, Department of Medical Microbiology, Bulgaria. Electronic address: markovska73@abv.bg.

Temenuga Stoeva (T)

Medical University of Varna, Department of Microbiology and Virology, University Multiprofile Hospital for Active Treatment (UMHAT), St Marina, Varna, Bulgaria.

Lyudmila Boyanova (L)

Medical University of Sofia, Medical Faculty, Department of Medical Microbiology, Bulgaria.

Petya Stankova (P)

Medical University of Sofia, Medical Faculty, Department of Medical Microbiology, Bulgaria.

Ines Schneider (I)

MICOER-Institute, Munich, Germany.

Emma Keuleyan (E)

Department of Clinical Microbiology, Medical Institute - Ministry of the Interior, Sofia, Bulgaria.

Kalina Mihova (K)

Molecular Medicine Center, Medical University of Sofia, Sofia, Bulgaria.

Marianna Murdjeva (M)

Medical University of Plovdiv, Department of Microbiology and Immunology, UMHAT, "St George", Plovdiv, Bulgaria.

Mariya Sredkova (M)

Medical University of Pleven, Department of Microbiology and Virology, UMHAT "Georgi Stranski", Pleven, Bulgaria.

Magdalena Lesseva (M)

Emergency Medical Institute "Pirogov", Sofia, Bulgaria.

Gergana Nedelcheva (G)

Medical University of Varna, Department of Microbiology and Virology, University Multiprofile Hospital for Active Treatment (UMHAT), St Marina, Varna, Bulgaria.

Atanaska Petrova (A)

Medical University of Plovdiv, Department of Microbiology and Immunology, UMHAT, "St George", Plovdiv, Bulgaria.

Dobrinka Ivanova (D)

Second Multiprofile Hospital for Active Treatment, Sofia, Bulgaria.

Grozdanka Lazarova (G)

UMHAT "Prof. dr St Kirkovich" Stara Zagora, Thracian University, Stara Zagora, Bulgaria.

Radka Kaneva (R)

Molecular Medicine Center, Medical University of Sofia, Sofia, Bulgaria.

Ivan Mitov (I)

Medical University of Sofia, Medical Faculty, Department of Medical Microbiology, Bulgaria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH